Cost of Stem Cell-Based Tissue-Engineered Airway Transplants in the United Kingdom: Case Series

Emily J Culme-Seymour(GlaxoSmithKline (United Kingdom)), Chris Mason(Oak Ridge National Laboratory), Claire Crowley, Martin Birchall(University of Bristol), Laura Vallejo‐Torres(Universidad de Las Palmas de Gran Canaria), Ed Toll(Great Ormond Street Hospital), Leanne Partington(Roland Hill (United Kingdom)), Colin R. Butler(Great Ormond Street Hospital), Carla Carvalho(The Royal Free Hospital), Martin J. Elliott(Great Ormond Street Hospital for Children NHS Foundation Trust), Katrina Mason(Queen Mary University of London), Mark W. Lowdell(Royal Free London NHS Foundation Trust)
Tissue Engineering Part A
November 12, 2015
10.1089/ten.tea.2015.0283
Cited by 24

Related Papers

A Brief Definition of Regenerative Medicine
|Regenerative Medicine|2007|795
BTRFS
|ACM Transactions on Storage|2013|381
Local and systemic responses to SARS-CoV-2 infection in children and adults
|Nature|2021|357
D-Transposition of the Great Arteries
|Journal of the American College of Cardiology|2014|287
Lancet Commission: Stem cells and regenerative medicine
|The Lancet|2017|276